Talk:Bilva: Difference between revisions
Dridhabala (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{#seo: | |||
|title=Charak Samhita | |||
|titlemode=append | |||
|keywords= Aegle marmelos, Bilva, Bilwa, Bael, stone apple, Charak Samhita, Dravyaguna, carakasamhitaonline, carakasamhita, caraka samhita, Ayurveda, Charak Samhita English translation, ancient Ayurveda text, Indian system of medicine, Ayurveda, Charak, Charaka Samhita, agnivesha, atreya, gopal basisht, yogesh deole, charak samhita wikipedia edition, charak samhita new edition, charaka samhita new edition, carak samhita new edition, caraka samhita new edition, research on charak samhita, text book charak samhita, fundamental principles of ayurveda, basic concepts of ayurveda, | |||
|description=Aegle marmelos (commonly known as bael, bilva, or stone apple) is a plant species in the family [[Rutaceae]] | |||
|image=http://www.carakasamhitaonline.com/resources/assets/ogimgs.jpg | |||
|image_alt=charak samhita | |||
|type=article | |||
}} | |||
Aegle marmelos (L.) CORREA EX. SCHULTZ | Aegle marmelos (L.) CORREA EX. SCHULTZ | ||
| Line 12: | Line 22: | ||
|data4 = Available | |data4 = Available | ||
|label5 = Contributors | |label5 = Contributors | ||
|data5 = | |data5 = Team Dravyaguna | ||
|label6 = Year of publication | |label6 = Year of publication | ||
|data6 = | |data6 = 2026 | ||
|label7 = Publisher | |label7 = Publisher | ||
|data7 = [[Charak Samhita Research, Training and Skill Development Centre]] | |data7 = [[Charak Samhita Research, Training and Skill Development Centre]] | ||
| Line 21: | Line 31: | ||
}} | }} | ||
'''''Aegle marmelos''''' (commonly known as '''bael''', '''bilva''', or '''stone apple''') is a plant species in the family [[Rutaceae]]. | |||
== | == Botanical profile and nomenclature == | ||
* '''Taxonomic name:''' ''Aegle marmelos'' (L.) Corrêa | |||
* '''Botanical synonyms:''' ''Crateva marmelos'' L., ''Feronia pellucida'' Roth, ''Belou marmelos'' (L.) W.Wight | |||
* '''Family:''' [[Rutaceae]] (Citrus family) | |||
* '''Sanskrit names:''' ''Bilva'', ''Sriphala'', ''Shandilya'', ''Shailusha'', ''Malura'', ''Pootivata'' | |||
* '''Vernacular names:''' Bael, Stone Apple, Golden Apple (English); Bel, Bael (Hindi/Bengali); Maredu (Telugu); Vilvam (Tamil); Baelu (Kannada); Koovalam (Malayalam); Kavit (Marathi). | |||
''Aegle marmelos'' is a medium-sized, slow-growing, deciduous spiny tree native to dry tropical and subtropical forests of the Indian subcontinent, Myanmar, and Thailand.<ref name="Sharma2011" /> It reaches heights of 8–15 meters and exhibits trifoliate, alternate leaves traditionally associated with religious symbolism in South Asia. The fruit is a globose or pyriform berry with a hard, woody outer shell (5–15 cm diameter) containing aromatic, mucilaginous orange pulp embedded with numerous woolly seeds. All morphological parts—including the unripe fruit, ripe fruit, root bark, leaves, and stem—possess distinct therapeutic profiles in classical Indian medicine. | |||
== | == Ayurvedic energetics and pharmacodynamics == | ||
In classical Ayurvedic pharmacology (''Dravyaguna''), ''Bilva'' presents a distinct dual-action profile depending on fruit maturity. Unripe fruit (''Ama Bilva'') is primary for intestinal and digestive pathology, whereas ripe fruit (''Pakva Bilva'') acts as a laxative but is heavier to digest. Leaves (''Bilva Patra'') and roots (''Bilva Mula'', a constituent of ''[[Dashamula]]'') possess potent ''Vata-Kapha'' pacifying properties. | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ Ayurvedic Pharmacodynamics of ''Bilva'' | ||
|- | |- | ||
! | ! Parameter !! Unripe fruit (''Ama Bilva'') !! Leaves (''Bilva Patra'') !! Root bark (''Bilva Mula'') | ||
|- | |- | ||
| | | '''Rasa''' (Taste) || ''Kashaya'' (Astringent), ''Tikta'' (Bitter) || ''Tikta'' (Bitter), ''Katu'' (Pungent) || ''Kashaya'' (Astringent), ''Madhura'' (Sweet) | ||
|- | |- | ||
| | | '''Guna''' (Qualities) || ''Laghu'' (Light), ''Ruksha'' (Dry) || ''Laghu'' (Light), ''Ruksha'' (Dry) || ''Laghu'' (Light) | ||
|- | |- | ||
| | | '''Virya''' (Potency) || ''Ushna'' (Hot) || ''Ushna'' (Hot) || ''Ushna'' (Hot) | ||
|- | |- | ||
| | | '''Vipaka''' (Post-digestive) || ''Katu'' (Pungent) || ''Katu'' (Pungent) || ''Katu'' (Pungent) | ||
|- | |- | ||
| | | '''Dosha Karma''' || ''Kapha-Vata Hara'' || ''Kapha-Vata Hara'' || ''Tridosha Hara'' (esp. ''Vata-Kapha'') | ||
|- | |- | ||
| '''Primary actions''' || ''Grahi'' (Absorbent), ''Deepana'' (Stomachic), ''Pachana'' (Digestive) || ''Mehahara'' (Antidiabetic), ''Shothahara'' (Anti-inflammatory) || ''Shothahara'' (Anti-edematous), ''Anulomana'' (Carminative) | |||
|- | |||
| '''Indications''' || ''Atisara'' (Diarrhea), ''Grahani'' (IBD/IBS), ''Pravahika'' (Dysentery) || ''Prameha'' (Diabetes), ''Jwara'' (Fever), ''Shotha'' (Swelling) || ''Vata-vyadhi'' (Neurological/Joint disorders), ''Vamana'' (Vomiting) | |||
|} | |} | ||
==Therapeutic uses== | |||
Pravahika, Agnimandya(loss of appetite), grahani roga<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume 01:18</ref> | |||
== Synonyms in Charak Samhita== | |||
Bilva, Shriphala(fruit of bilva is having aroma), Shandilya, Malur, Mahaphala(fruit is large in size), Sadaphala(bilva bears fruits always) | |||
==Synonyms in Bhavaprakasa Nighantu== | |||
Shandilya, Shailusha(Bilva tree grows in hilly region also),malura<ref> Pro. Krushnachandra Chunekar, Bhavaprakash Nighantu. Reprint Edition 2020, Chaukhambha Bharati Academy, Guduchyadi varga, verse no.-13</ref> | |||
== Reference in Charak Samhita and its actions == | == Reference in Charak Samhita and its actions == | ||
| Line 74: | Line 99: | ||
| 4 | | 4 | ||
| Cha.Sa.[[Sutra Sthana]] 2/28 | | Cha.Sa.[[Sutra Sthana]] 2/28 | ||
| | | Grahi yavagu | ||
|- | |- | ||
| 5 | | 5 | ||
| Cha.Sa.[[Sutra Sthana]] 4/9(12) | | Cha.Sa.[[Sutra Sthana]] 4/9(12) | ||
| | | Arshoghna mahakashaya (anti-hemorrhoids) | ||
|- | |- | ||
| 6 | | 6 | ||
| Cha.Sa.[[Sutra Sthana]] 4/9(25) | | Cha.Sa.[[Sutra Sthana]] 4/9(25) | ||
| | | Asthapanopaga mahakashaya(helping corrective enema) | ||
|- | |- | ||
| 7 | | 7 | ||
| Cha.Sa.[[Sutra Sthana]] 4/9(26) | | Cha.Sa.[[Sutra Sthana]] 4/9(26) | ||
| | | Anuvasanopaga mahakashaya(unctuous enema) | ||
|- | |- | ||
| 8 | | 8 | ||
| Cha.Sa.[[Sutra Sthana]] 4/9(38) | | Cha.Sa.[[Sutra Sthana]] 4/9(38) | ||
| | | Shwayathuhara mahakashaya(relieving oedema) | ||
|- | |- | ||
| 9 | | 9 | ||
| Cha.Sa.[[Sutra Sthana]] 5/64 | | Cha.Sa.[[Sutra Sthana]] 5/64 | ||
| | | Anu taila dravya | ||
|- | |- | ||
| 10 | | 10 | ||
| Cha.Sa.[[Sutra Sthana]] 13/10 | | Cha.Sa.[[Sutra Sthana]] 13/10 | ||
| Sthavara | | Sthavara Sneha Yoni (Vegetable origin of lipids) | ||
|- | |- | ||
| 11 | | 11 | ||
| Cha.Sa.[[Sutra Sthana]] 21/24 | | Cha.Sa.[[Sutra Sthana]] 21/24 | ||
| Management of | | Management of obesity | ||
|- | |- | ||
| 12 | | 12 | ||
| Line 134: | Line 159: | ||
| 19 | | 19 | ||
| Cha.Sa.[[Chikitsa Sthana]] 1/1/43 | | Cha.Sa.[[Chikitsa Sthana]] 1/1/43 | ||
| In formulation of | | In formulation of Brahma rasayana | ||
|- | |- | ||
| 20 | | 20 | ||
| Cha.Sa.[[Chikitsa Sthana]] 3/183 | | Cha.Sa.[[Chikitsa Sthana]] 3/183 | ||
| Used as peya with amla in | | Used as peya with amla in Jwara atisara | ||
|- | |- | ||
| 21 | | 21 | ||
| Line 186: | Line 211: | ||
| 32 | | 32 | ||
| Cha.Sa.[[Chikitsa Sthana]] 8/126 | | Cha.Sa.[[Chikitsa Sthana]] 8/126 | ||
| Ingredient in Atisar nashak | | Ingredient in Atisar nashak Yoga | ||
|- | |- | ||
| 33 | | 33 | ||
| Cha.Sa.[[Chikitsa Sthana]] 8/127 | | Cha.Sa.[[Chikitsa Sthana]] 8/127 | ||
| Ingredient in Atisar nashak | | Ingredient in Atisar nashak Yoga | ||
|- | |- | ||
| 34 | | 34 | ||
| Cha.Sa.[[Chikitsa Sthana]] 8/168 | | Cha.Sa.[[Chikitsa Sthana]] 8/168 | ||
| Ingredient in Rajayakshma | | Ingredient in Rajayakshma nasak Ghrita | ||
|- | |- | ||
| 35 | | 35 | ||
| Line 230: | Line 255: | ||
| 43 | | 43 | ||
| Cha.Sa.[[Chikitsa Sthana]] 14/47 | | Cha.Sa.[[Chikitsa Sthana]] 14/47 | ||
| Used in | | Used in avagaha sweda | ||
|- | |- | ||
| 44 | | 44 | ||
| Line 250: | Line 275: | ||
| 48 | | 48 | ||
| Cha.Sa.[[Chikitsa Sthana]] 14/107 | | Cha.Sa.[[Chikitsa Sthana]] 14/107 | ||
| As an ingredient of | | As an ingredient of chavyadi ghrita | ||
|- | |- | ||
| 49 | | 49 | ||
| Line 258: | Line 283: | ||
| 50 | | 50 | ||
| Cha.Sa.[[Chikitsa Sthana]] 14/131 | | Cha.Sa.[[Chikitsa Sthana]] 14/131 | ||
| Used in | | Used in anuvasana basti | ||
|- | |- | ||
| 51 | | 51 | ||
| Cha.Sa.[[Chikitsa Sthana]] 14/144 | | Cha.Sa.[[Chikitsa Sthana]] 14/144 | ||
| As an ingredient of | | As an ingredient of dantyarishta | ||
|- | |- | ||
| 52 | | 52 | ||
| Cha.Sa.[[Chikitsa Sthana]] 14/195 | | Cha.Sa.[[Chikitsa Sthana]] 14/195 | ||
| Used in rakta | | Used in rakta arsha shoola | ||
|- | |- | ||
| 53 | | 53 | ||
| Cha.Sa.[[Chikitsa Sthana]] 14/200 | | Cha.Sa.[[Chikitsa Sthana]] 14/200 | ||
| Used in rakta | | Used in rakta arsha | ||
|- | |- | ||
| 54 | | 54 | ||
| Line 294: | Line 319: | ||
| 59 | | 59 | ||
| Cha.Sa.[[Chikitsa Sthana]] 15/129 | | Cha.Sa.[[Chikitsa Sthana]] 15/129 | ||
| As an ingredient of | | As an ingredient of Nagaradya churna | ||
|- | |- | ||
| 60 | | 60 | ||
| Line 322: | Line 347: | ||
| 66 | | 66 | ||
| Cha.Sa.[[Chikitsa Sthana]] 17/102 | | Cha.Sa.[[Chikitsa Sthana]] 17/102 | ||
| Used in yavagu preparation for hikka | | Used in yavagu preparation for hikka shvasa | ||
|- | |- | ||
| 67 | | 67 | ||
| Line 330: | Line 355: | ||
| 68 | | 68 | ||
| Cha.Sa.[[Chikitsa Sthana]] 17/140 | | Cha.Sa.[[Chikitsa Sthana]] 17/140 | ||
| As an ingredient of | | As an ingredient of dashamuladya ghrita | ||
|- | |- | ||
| 69 | | 69 | ||
| Line 346: | Line 371: | ||
| 72 | | 72 | ||
| Cha.Sa.[[Chikitsa Sthana]] 18/123 | | Cha.Sa.[[Chikitsa Sthana]] 18/123 | ||
| As an ingredient of | | As an ingredient of dashamuladi ghrita | ||
|- | |- | ||
| 73 | | 73 | ||
| Line 354: | Line 379: | ||
| 74 | | 74 | ||
| Cha.Sa.[[Chikitsa Sthana]] 19/26 | | Cha.Sa.[[Chikitsa Sthana]] 19/26 | ||
| As a | | As a Ingreidient of dipaniya and sangrahi gana | ||
|- | |- | ||
| 75 | | 75 | ||
| Line 374: | Line 399: | ||
| 79 | | 79 | ||
| Cha.Sa.[[Chikitsa Sthana]] 19/52 | | Cha.Sa.[[Chikitsa Sthana]] 19/52 | ||
| As a yoga dravya in treatment of | | As a yoga dravya in treatment of pittaja atisara | ||
|- | |- | ||
| 80 | | 80 | ||
| Line 442: | Line 467: | ||
| 96 | | 96 | ||
| Cha.Sa.[[Chikitsa Sthana]] 27/56 | | Cha.Sa.[[Chikitsa Sthana]] 27/56 | ||
| As an ingredient of Shyonakadi Parisheka and | | As an ingredient of Shyonakadi Parisheka and Pralepa | ||
|- | |- | ||
| 97 | | 97 | ||
| Line 466: | Line 491: | ||
| 102 | | 102 | ||
| Cha.Sa.[[Chikitsa Sthana]] 29/104 | | Cha.Sa.[[Chikitsa Sthana]] 29/104 | ||
| As an ingredient of | | As an ingredient of Amrutadya taila | ||
|- | |- | ||
| 103 | | 103 | ||
| Line 488: | Line 513: | ||
* Bilvadi leha | * Bilvadi leha | ||
* Bruhatagangadhara churna | * Bruhatagangadhara churna | ||
== Current availability== | == Current availability== | ||
| Line 496: | Line 520: | ||
== Current researches == | == Current researches == | ||
== Phytochemical profile == | |||
Chemical characterization of ''Aegle marmelos'' across various tissues has identified over 100 secondary metabolites.<ref name="Dhankhar2011" /><ref name="Baliga2011" /> The principal active phytochemical groups include: | |||
* '''Coumarins and furanocoumarins:''' Marmelosin (imperatorin), marmin, umbelliferone, scopoletin, psoralen, aurapten, and xanthotoxol. Marmelosin represents the primary bio-marker constituent responsible for gastroprotective and anti-diarrheal activity.<ref name="Sharma2011" /> | |||
* '''Alkaloids:''' Aegeline, marmeline, shahimspine, fragrine, O-methylhalfordinol, and aegelenine.<ref name="Dhankhar2011" /> Aegeline exhibits metabolic regulatory effects. | |||
* '''Triterpenoids and sterols:''' β-sitosterol, lupeol, and γ-sitosterol. | |||
* '''Phenolics and flavonoids:''' Rutin, quercetin, ferulic acid, chlorogenic acid, tannic acid, and gallic acid.<ref name="Pathirana2020" /> | |||
* '''Polysaccharides and essential oils:''' Mucilage and pectins (fruit pulp); limonene, α-phellandrene, ''p''-cymene, and cineole (leaf essential oil). | |||
== Therapeutic efficacy and pharmacological profile == | |||
=== Anti-diarrheal, anti-dysenteric, and gastroprotective activity === | |||
The primary historical clinical use of unripe ''Bilva'' fruit is in managing inflammatory bowel conditions, infectious diarrhea, and irritable bowel syndrome (IBS). | |||
* '''Mechanisms of action:''' Unripe fruit extracts rich in marmelosin, tannins, and mucilage exhibit antisecretory and antimotility effects. Research demonstrates that aqueous and methanolic extracts significantly reduce castor oil-induced and enterotoxin-induced intestinal fluid accumulation and peristalsis.<ref name="Bhowmik2012" /> | |||
* '''Antimicrobial action against enteropathogens:''' ''A. marmelos'' extracts inhibit colonization and toxin production of enteropathogenic bacteria including ''Escherichia coli'', ''Vibrio cholerae'', ''Shigella dysenteriae'', and ''Salmonella typhimurium''.<ref name="Rajan2011" /> | |||
* '''Ulcer protective effect:''' Marmelosin and mucosal polysaccharides enhance gastric mucosal resistance, stimulate mucin secretion, and neutralize gastric hyperacidity, showing efficacy comparable to ranitidine in ethanol- and indomethacin-induced ulcer models.<ref name="Baliga2011" /> | |||
=== Antidiabetic and hypoglycemic activity === | |||
Leaf and fruit extracts of ''Aegle marmelos'' possess potent blood-glucose-lowering properties, validating its use in traditional management of ''Prameha'' (metabolic syndrome). | |||
* '''Mechanisms of action:''' Aqueous leaf extract improves systemic glucose tolerance by increasing peripheral glucose uptake, enhancing hepatic glycogen synthesis, and suppressing gluconeogenic enzymes (fructose-1,6-bisphosphatase and glucose-6-phosphatase).<ref name="Gandhi2012" /> | |||
* '''Pancreatic beta-cell protection:''' Histopathological evaluations show that administration of ''A. marmelos'' extract in streptozotocin-induced diabetic models promotes regeneration of pancreatic β-cells and increases serum insulin secretion.<ref name="Sharma2011" /> | |||
* '''Enzyme inhibition:''' Extracts demonstrate strong competitive inhibition against α-glucosidase and α-amylase, delaying postprandial glucose absorption.<ref name="Pathirana2020" /> | |||
=== Anti-inflammatory, analgesic, and antipyretic properties === | |||
The root bark and leaf preparations suppress systemic inflammation, joint pain, and fever. | |||
* '''Mechanisms of action:''' Methanolic leaf and root extracts inhibit carrageenan-induced paw edema and cotton pellet granuloma in animal models.<ref name="Patel2012" /> Bioactive coumarins (marmin and umbelliferone) downregulate key inflammatory mediators, including cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6).<ref name="Baliga2011" /> | |||
=== Antioxidant and hepatoprotective activity === | |||
Free radical damage drives many chronic hepatic and systemic pathologies. ''A. marmelos'' leaves and fruit pulp contain high concentrations of polyphenols and flavonoids that scavenge reactive oxygen species (ROS). | |||
* '''Mechanisms of action:''' Administration of ''A. marmelos'' restores depleted endogenous antioxidant enzymes—superoxide dismutase (SOD), catalase (CAT), and reduced glutathione (GSH)—while reducing malondialdehyde (MDA) levels in lipid peroxidation assays.<ref name="Jagetia2005" /> | |||
* '''Hepatoprotection:''' In carbon tetrachloride (CCl<sub>4</sub>)- and alcohol-induced hepatotoxicity models, ''Bilva'' extract significantly reduces elevated serum biomarkers: aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and total bilirubin, restoring normal liver architecture.<ref name="Sharma2011" /> | |||
=== Cardioprotective and antihyperlipidemic activity === | |||
* '''Cardioprotection:''' Pre-treatment with ''A. marmelos'' leaf extract attenuates isoproterenol-induced myocardial infarction by preventing membrane phospholipid degradation, maintaining intracellular enzyme leakage (CK-MB, LDH), and mitigating oxidative stress.<ref name="Prince2005" /> | |||
* '''Lipid modulation:''' Extracts lower total cholesterol, low-density lipoprotein (LDL), and triglycerides while elevating high-density lipoprotein (HDL) levels in hyperlipidemic models.<ref name="Gandhi2012" /> | |||
== Dosage, formulations, and safety profile == | |||
=== Classical formulations === | |||
# '''Bilvadi Churna:''' Powdered combination of unripe ''Bilva'', ''Mocharasa'', ''Musta'', and ''Dhataki'' used for acute diarrhea, dysentery, and IBS. | |||
# '''Bilvashtaka Churna:''' Traditional polyherbal formulation prescribed for intestinal malabsorption (''Grahani'') and sluggish digestion. | |||
# '''Bilvadilehya (Bilvadi Lehya):''' Herbal jam formulation indicated for chronic diarrhea, hyperacidity, vomiting, and nausea. | |||
# '''Dashamularishta / Dashamula Kwatha:''' Complex decoction and fermented tonic incorporating ''Bilva'' root as a primary anti-inflammatory agent. | |||
# '''Bilva Taila:''' Medicated sesame oil infused with ''Bilva'' fruit processed for ear ailments (''Karnaroga''), particularly tinnitus and hard of hearing. | |||
=== Recommended posology (raw drug) === | |||
* '''Unripe fruit powder (''Churna''):''' 2–6 grams daily with warm water or buttermilk. | |||
* '''Leaf powder (''Churna''):''' 3–6 grams daily. | |||
* '''Leaf juice (''Swarasa''):''' 10–20 mL daily. | |||
* '''Root bark decoction (''Kwatha''):''' 50–100 mL daily in divided doses. | |||
* '''Fresh fruit pulp (ripe):''' 50–100 grams (used as a seasonal cooling beverage). | |||
=== Toxicology and safety === | |||
''Aegle marmelos'' exhibits a broad therapeutic window and high safety profile. Acute toxicity studies in rodents with aqueous and alcoholic leaf/fruit extracts showed no mortality or adverse behavioral parameters up to single doses of 2000 mg/kg body weight (NOAEL).<ref name="Baliga2011" /> | |||
* '''Precautions:''' Ripe fruit pulp is heavy to digest (''Guru'') and, if consumed excessively over prolonged periods, can cause intestinal bloating and constipation due to high pectin and mucosal content. Unripe fruit formulations should be discontinued once acute diarrhea or dysentery resolves to avoid excessive astringent (''Stambhana'') activity. | |||
== References == | |||
{{reflist|refs= | |||
<ref name="Baliga2011">Baliga, M. S., Thilak, C., Haniadka, R., Rao, S., & Arora, R. (2011). Evaluation of the antiinflammatory, analgesic, and antipyretic activities of ''Aegle marmelos'' (L.) Correa. ''Journal of Alternative and Complementary Medicine'', 17(11), 1023–1029. https://doi.org/10.1089/acm.2010.0534</ref> | |||
<ref name="Bhowmik2012">Bhowmik, D., Kumar, K. S., Yadav, A., Srivastava, S., Paswan, S., & Dutta, A. S. (2012). Recent trends in Indian traditional herb ''Aegle marmelos'' and its medicinal potential. ''The Pharma Innovation'', 1(4), 12–22.</ref> | |||
<ref name="Dhankhar2011">Dhankhar, S., Ruhil, S., Balhara, M., Dhankhar, S., & Chhillar, A. K. (2011). ''Aegle marmelos'' (Linn.) Correa: A potential source of phytomedicine. ''Journal of Medicinal Plants Research'', 5(9), 1497–1507.</ref> | |||
<ref name="Gandhi2012">Gandhi, G. R., & Sasikumar, P. (2012). Antidiabetic, antihyperlipidemic and antioxidant activity of ''Aegle marmelos'' (L.) Corr. leaf extract in streptozotocin-induced diabetic rats. ''Asian Pacific Journal of Tropical Biomedicine'', 2(3), S115–S122. https://doi.org/10.1016/S2221-1691(12)60140-1</ref> | |||
<ref name="Jagetia2005">Jagetia, G. C., Venkatesh, P., & Baliga, M. S. (2005). Evaluation of the radioprotective effect of ''Aegle marmelos'' (L.) Correa in cultured human peripheral blood lymphocytes. ''Phytomedicine'', 12(1-2), 112–119. https://doi.org/10.1016/j.phymed.2003.09.006</ref> | |||
<ref name="Patel2012">Patel, P. K., Patel, M. A., Vyas, B. A., Shah, D. R., & Gandhi, T. R. (2012). Antinociceptive and anti-inflammatory activity of ''Aegle marmelos'' leaves. ''International Journal of Green Pharmacy'', 6(1), 23–28.</ref> | |||
<ref name="Pathirana2020">Pathirana, C. K., Madhujith, T., & Eeswara, J. (2020). Bael (''Aegle marmelos'' (L.) Corrêa), a versatile medicinal plant: A review on chemical constituents and bioactivities. ''Journal of Pharmacognosy and Phytochemistry'', 9(2), 1619–1629.</ref> | |||
<ref name="Prince2005">Prince, P. S. M., & Rajadurai, M. (2005). Preventive effect of ''Aegle marmelos'' leaf extract on isoprenaline-induced myocardial infarction in rats. ''Journal of Pharmacy and Pharmacology'', 57(10), 1353–1358. https://doi.org/10.1211/jpp.57.10.0015</ref> | |||
<ref name="Rajan2011">Rajan, S., Gokila, M., Jancy, P., Brindha, P., & Sujatha, R. (2011). Antioxidant and phytochemical properties of ''Aegle marmelos'' fruit pulp. ''International Journal of Pharmacy and Pharmaceutical Sciences'', 3(2), 159–163.</ref> | |||
<ref name="Sharma2011">Sharma, G. N., Dubey, S. K., Sati, N., & Sanadya, J. (2011). ''Aegle marmelos'' (Linn.) Correa: A potential medicinal plant for pharmaceuticals. ''World Journal of Pharmaceutical Research'', 1(1), 10–30.</ref> | |||
}} | |||
[[Category: Database of herbs and minerals | Herbs]] | == External links== | ||
* [https://cb.imsc.res.in/imppat/phytochemical/Aegle%20marmelos IMPPAT database] | |||
* [[Category: Database of herbs and minerals | Herbs]] | |||